2012
DOI: 10.33588/rn.5510.2012295
|View full text |Cite
|
Sign up to set email alerts
|

Situación de partida y abordaje asistencial de la migraña en las consultas de neurología de España. Estudio PRIMERA

Abstract: Pacientes y métodos. Estudio transversal y multicéntrico, realizado en consultas de neurología de todo el territorio nacional. Participaron 168 neurólogos que reclutaron un total de 851 pacientes (74,6% mujeres; edad media: 34,0 ± 10,7 años). La discapacidad se evaluó mediante el cuestionario específico para migraña (Headache Impact Test) y el cuestionario de discapacidad genérico (Sheehan Disability Scale). Resultados. El 66,5% de los pacientes consultó por consejo médico, el 33,5% restante lo hizo por inicia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
(22 reference statements)
0
1
0
Order By: Relevance
“…For example, in Spain less than 20% of migraine patients receive the prescription of a triptan (of choice in the symptomatic treatment of moderate-intense crises), ergotics and opioids are still prescribed to a significant number of patients although we know that they induce headache chronicity and there is an underuse of preventive treatment. 20 As for diagnostic barriers, and probably due to an excessively sharp interpretation of the diagnostic criteria of the different primary headaches, the classification of the different headaches remains a problem for primary headaches, which is undoubtedly one of the causes that justify the excess of diagnostic tests, also identified as a barrier. 21 22 The results of this study, which identify the main barriers in the care pathway for headache patients, could help to introduce the necessary organisational modifications to achieve optimal quality of care following the standards that the European scientific literature has indicated as appropriate.…”
Section: Discussionmentioning
confidence: 99%
“…For example, in Spain less than 20% of migraine patients receive the prescription of a triptan (of choice in the symptomatic treatment of moderate-intense crises), ergotics and opioids are still prescribed to a significant number of patients although we know that they induce headache chronicity and there is an underuse of preventive treatment. 20 As for diagnostic barriers, and probably due to an excessively sharp interpretation of the diagnostic criteria of the different primary headaches, the classification of the different headaches remains a problem for primary headaches, which is undoubtedly one of the causes that justify the excess of diagnostic tests, also identified as a barrier. 21 22 The results of this study, which identify the main barriers in the care pathway for headache patients, could help to introduce the necessary organisational modifications to achieve optimal quality of care following the standards that the European scientific literature has indicated as appropriate.…”
Section: Discussionmentioning
confidence: 99%